Cover Image

Clinical trajectories and medication response in TBC1D24 ‐related epilepsies

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Ealing Mondragon, Jan H. Magielski, Bintou Bane, JoeyLynn Nolan, Sarah M. Ruggiero, Dallas Armstrong, Susan Arnold, Deepa Sirsi, Ingo Helbig, Jillian L. McKee
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Epilepsia
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy
by: Alicia G. Harrison, et al.
Published: (2025)

Expanding the longitudinal trajectory and genotypes of TBC1D24 ‐related epilepsy
by: Songyang Xiang, et al.
Published: (2026)

Genetic testing for familial epilepsies: Diagnostic yield and genetic findings
by: Colin A. Ellis, et al.
Published: (2026)

Early life seizures and epileptic spasms in STXBP1‐related disorders
by: Kim M. Thalwitzer, et al.
Published: (2024)

Agreement and 2‐year trajectories of youth‐ and parent‐reported health‐related quality of life in youth with epilepsy treated with surgery vs medical therapy
by: Mary Lou Smith, et al.
Published: (2026)

Which is the most cost‐effective antiseizure medication for initial monotherapy for focal epilepsy?
by: Yani Hu, et al.
Published: (2025)

Impact of antiseizure medication taper on electroencephalographic dynamics in focal epilepsy: A stereoelectroencephalographic study
by: Guoping Ren, et al.
Published: (2026)

Anti‐seizure medications in patients with post‐stroke epilepsy: A survival analysis study
by: Ippazio Cosimo Antonazzo, et al.
Published: (2025)

Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States
by: Adam P. Ostendorf, et al.
Published: (2026)

Neurodevelopmental trajectories and clinical outcomes following ultra‐early epilepsy surgery in infants: A matched cohort study
by: Hai‐Qing Zhao, et al.
Published: (2026)

Factors associated with placebo response rate in randomized controlled trials of antiseizure medications for focal epilepsy
by: Wesley T. Kerr, et al.
Published: (2024)

Prescribing patterns for higher dose folic acid in pregnant women with epilepsy treated with antiseizure medication
by: Håkon Magne Vegrim, et al.
Published: (2024)

Do the third‐generation antiseizure medications provide the “magic bullet” for drug‐resistant epilepsy? Focus on cenobamate
by: Patrick Kwan, et al.
Published: (2025)

Differences in patterns of outpatient epilepsy‐specific medication initiation after acute ischemic stroke in the Medicare population
by: Maria A. Donahue, et al.
Published: (2025)

User involvement in the design and development of medical devices in epilepsy: A systematic review
by: João Ferreira, et al.
Published: (2024)

Association of first antiseizure medication with acute health care utilization in a cohort of adults with newly diagnosed epilepsy
by: Leah J. Blank, et al.
Published: (2024)

Assessment of antiseizure medication adherence based on postmortem toxicology and claimed prescriptions in cases of sudden unexpected death in epilepsy
by: Marie Kroman Palsøe, et al.
Published: (2025)

EEG signal dimension is an index of seizure propensity and antiseizure medication effects in a mouse model of acquired epilepsy
by: Massimo Rizzi, et al.
Published: (2025)

Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications
by: Michael R. Sperling, et al.
Published: (2025)

Treatment of epilepsy using newer antiseizure medications: A retrospective cohort study of prescription patterns in Sweden 2013–2022
by: Kristian Bolin, et al.
Published: (2025)

Association of maternal epilepsy with perinatal outcomes, and an exploration of prenatal antiseizure medication: A population‐based retrospective cohort study
by: Paolo Pieirino Mazzone, et al.
Published: (2025)

The cerebellum in epilepsy
by: Christopher Elder, et al.
Published: (2025)

The association between structural connectivity and anti‐seizure medication response in patients with temporal lobe epilepsy
by: Dong Ah Lee, et al.
Published: (2024)

Longitudinal analyses of electronic medical records reveal dynamic developmental trajectories for patients with SCN8A ‐related disorders
by: Kiran Smelser, et al.
Published: (2025)

Plasma metabolome reveals altered oxidative stress, inflammation, and amino acid metabolism in dogs with idiopathic epilepsy
by: Fien Verdoodt, et al.
Published: (2025)

Multicentric study of adherence to antiseizure medications among adults with epilepsy attended in neurology departments in Burkina Faso
by: Alfred Anselme Dabilgou, et al.
Published: (2024)

May anti‐seizure medications alter brain structure in temporal lobe epilepsy? A prospective study
by: Ilaria Sammarra, et al.
Published: (2024)

SCN8A self‐limited infantile epilepsy: Does epilepsy resolve?
by: Emma Young, et al.
Published: (2024)

Phenotypic heterogeneity in familial epilepsies is influenced by polygenic risk for generalized and focal epilepsies
by: Colin A. Ellis, et al.
Published: (2025)

Correlations between antiseizure medications and interictal epileptiform discharges in the idiopathic generalized epilepsies: A retrospective exploratory analysis of home video‐electroencephalographic studies
by: Basheer Arnaout, et al.
Published: (2025)

The human photosensitive epilepsy model for clinical proof‐of‐principle trials of novel antiseizure medications. 1. Use of the EEG in drug development and characteristics of the model
by: Dorothée Kasteleijn‐Nolst Trenité, et al.
Published: (2025)

Extracellular vesicle microRNAs are biomarkers of focal epilepsy but not epilepsy‐related respiratory dysfunction
by: Sylvain Rheims, et al.
Published: (2025)

Executive dysfunction and employment in epilepsy
by: Lisa E. Hauger, et al.
Published: (2026)

Artificial intelligence in epilepsy phenotyping
by: Andrew Knight, et al.
Published: (2024)

Prospective study of epilepsy with generalized tonic–clonic seizures alone: Clinical features, response to treatment, and likelihood of medication withdrawal
by: Fatima Jaafar, et al.
Published: (2024)

Cannabinoid‐like compounds found in non‐cannabis plants exhibit antiseizure activity in genetic mouse models of drug‐resistant epilepsy
by: Ka Lai Yip, et al.
Published: (2024)

Functional connectivity in self‐limited epilepsy with centrotemporal spikes increases with epilepsy duration and interictal spike exposure
by: Marie E. Vasitas, et al.
Published: (2026)

Pharmacogenomics in epilepsy care across Asia
by: Anushika Raheja, et al.
Published: (2026)

Theory of mind in juvenile myoclonic epilepsy
by: Rafael Gustavo Sato Watanabe, et al.
Published: (2025)

Vitamin D prophylaxis in persons with epilepsy?
by: Jo Sourbron, et al.
Published: (2024)